Gaudium IVF is set to launch its IPO but governance experts are flagging intra-group financial transactions and tax investigations. A promoter’s substantial share sale and high professional fees raise questions, with concerns about promoter revenue streams and compliance.
Gaudium IVF is set to launch its IPO but governance experts are flagging intra-group financial transactions and tax investigations. A promoter’s substantial share sale and high professional fees raise questions, with concerns about promoter revenue streams and compliance. by Soban News (international And National News)
